Dr Fresh Assets Annual Reports, Balance Sheet and Financials

Dr Fresh Assets Limited Balance Sheet (Rs in Lakhs)

Dr Fresh Assets Limited Profit & Loss Statement (Rs in Lakhs)

 Dr Fresh Assets Limited Consolidated Cash Flow Statement (Rs in Lakhs)

Here is a summary of the Cash Flow Statement for the years 2024 and 2023:

Cash Flow from Operating Activities

Net Profit Before Adjustments: The company reported a profit before tax and after impairment of Rs. 204.72 lakhs in 2024, an increase from Rs. 108.39 lakhs in 2023.

Adjustments: Key adjustments included non-cash and non-operating items such as interest income, finance charges, depreciation, provision adjustments, exchange fluctuations, and asset sales. Notably, there was a significant reversal of provisions and liabilities in 2024, with Rs. 92.40 lakhs written back, which impacted the cash flow.

Working Capital Changes: Changes in inventories, receivables, payables, and other current assets influenced cash inflow. In particular, receivables decreased by Rs. 54.20 lakhs, indicating improved collections.

Net Cash from Operations: After adjusting for taxes paid, the net cash from operating activities totaled Rs. 59.44 lakhs in 2024, down from Rs. 343.05 lakhs in 2023, reflecting the impact of increased provisions and other adjustments.

Cash Flow from Investing Activities

Investments and Asset Purchases: The company spent Rs. 17.67 lakhs on purchasing fixed assets in 2024, a slight increase from Rs. 4.35 lakhs in 2023. Investments in securities also rose.

Proceeds from Investment Sales and Loans: The sale of investments contributed Rs. 121.37 lakhs in 2024, while short-term loans repayments decreased, reducing cash inflow. Interest income saw a boost, generating Rs. 45.03 lakhs in 2024.

Net Cash Used in Investing Activities: There was a net positive cash flow of Rs. 48.37 lakhs from investing activities in 2024, though lower than Rs. 114.92 lakhs in 2023 due to increased asset purchases.

Cash Flow from Financing Activities

Loans and Finance Costs: The company had repayments of short-term loans amounting to Rs. 189.10 lakhs in 2024, a significant reduction from the prior year. Interest payments were reduced as well, standing at Rs. 6.94 lakhs.

Equity Infusion: Proceeds from share application money added Rs. 6.09 lakhs to financing inflows.

Net Cash Used in Financing Activities: The financing activities resulted in a net outflow of Rs. 189.95 lakhs in 2024, slightly lower than the Rs. 684.15 lakhs outflow in 2023, mainly due to reduced loan repayments.

Net Change in Cash and Cash Equivalents

Overall Cash Movement: The company saw a net decrease in cash and cash equivalents of Rs. 82.15 lakhs in 2024, reflecting lower operating and investing cash inflows compared to 2023.

Opening and Closing Balances: The cash and cash equivalents balance decreased from Rs. 178.14 lakhs at the beginning of the year to Rs. 96.00 lakhs by year-end 2024.

Financial Ratios of Dr Fresh Assets Limited

Here is a summary of the financial and operational metrics for Dr Fresh Assets Limited for the year 2024 and 2023:

Current Ratio:

The current ratio increased slightly to 2.03 in 2024 from 1.9 in 2023. This indicates an improvement in the company's ability to cover its short-term liabilities with its current assets, signaling adequate liquidity for near-term obligations.

Debt to Equity Ratio:

The debt-to-equity ratio decreased from 0.22 in 2023 to 0.15 in 2024. A lower ratio here suggests that the company relies less on debt financing, which could indicate a more conservative approach to leveraging its operations, or improved equity base.

Debt Service Coverage Ratio:

The debt service coverage ratio rose significantly to 0.94 from 0.17. While it remains below 1.0, this increase indicates that the company has improved its ability to cover debt obligations through its earnings, though it still may face challenges in fully covering interest and principal payments.

Return on Equity (ROE):

The return on equity increased from 2.06% in 2023 to 3.37% in 2024, indicating improved profitability relative to shareholders’ equity. This shows that the company is generating higher returns on equity, enhancing shareholder value.

Inventory Turnover Ratio:

The inventory turnover ratio decreased slightly from 0.4 in 2023 to 0.37 in 2024, which may indicate slower movement of inventory. This could suggest potential inefficiencies in inventory management, potentially leading to higher holding costs or stale inventory.

Trade Receivables Turnover Ratio:

This ratio increased to 0.79 in 2024 from 0.62 in 2023, suggesting that the company is collecting receivables more frequently over the period, leading to better cash flow from its sales.

Trade Payables Turnover Ratio:

The increase from 2.88 in 2023 to 7.48 in 2024 shows that the company is paying off suppliers more frequently. This may reflect tighter management of payables or better credit terms, enhancing the company's credibility with suppliers.

Net Capital Turnover Ratio:

The net capital turnover ratio decreased from 0.25 to 0.21, suggesting that sales generation relative to working capital has slightly decreased. This indicates less efficiency in generating sales from net working capital.

Net Profit Ratio:

The net profit ratio improved significantly from 16.13% in 2023 to 32.82% in 2024, indicating better control over costs relative to revenue or a significant increase in profitability, both of which strengthen the company’s financial health.

Return on Capital Employed (ROCE):

ROCE doubled from 0.02% to 0.04%, reflecting better returns on the capital employed in the business. While still low, this increase suggests a gradual improvement in using capital for productive returns.

Return on Investment (ROI):

The ROI increased significantly from 4.56% in 2023 to 18.05% in 2024. This suggests that investments made by the company are generating much higher returns, indicating successful investment decisions and efficient use of capital.